Clinical Trials Browser

Phase 2 × Active not recruiting × derazantinib × Clear all

NCT05174650 2025-12-05

Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements

Phase 2 Active not recruiting

Gastrointestinal

Cholangiocarcinoma